In this review, we focus particularly on lipid metabolism in embryonal tumors with deregulated MYCN function, specifically neuroblastoma, retinoblastoma, Wilms tumor, medulloblastoma, and rhabdomyosarcoma. Here, MYCN is linked to neuroblastoma.